These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 18762384

  • 1. Injecting drug users' understanding of hepatitis C.
    O'Brien S, Day C, Black E, Dolan K.
    Addict Behav; 2008 Dec; 33(12):1602-5. PubMed ID: 18762384
    [Abstract] [Full Text] [Related]

  • 2. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
    Smyth BP, Barry J, Keenan E.
    Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
    [Abstract] [Full Text] [Related]

  • 3. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
    Doab A, Treloar C, Dore GJ.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S313-20. PubMed ID: 15768340
    [Abstract] [Full Text] [Related]

  • 6. Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.
    Wand H, Spiegelman D, Law M, Jalaludin B, Kaldor J, Maher L.
    Addiction; 2009 Dec 15; 104(12):2049-56. PubMed ID: 19804463
    [Abstract] [Full Text] [Related]

  • 7. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
    Maher L, Jalaludin B, Chant KG, Jayasuriya R, Sladden T, Kaldor JM, Sargent PL.
    Addiction; 2006 Oct 15; 101(10):1499-508. PubMed ID: 16968352
    [Abstract] [Full Text] [Related]

  • 8. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada.
    Wozniak L, Prakash M, Taylor M, Wild TC.
    Int J Drug Policy; 2007 Oct 15; 18(5):388-96. PubMed ID: 17854727
    [Abstract] [Full Text] [Related]

  • 9. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B, Narayanan S, Navaratnam V.
    Drug Alcohol Rev; 2009 Jul 15; 28(4):447-54. PubMed ID: 19594801
    [Abstract] [Full Text] [Related]

  • 10. Peer-delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users.
    Aitken CK, Kerger M, Crofts N.
    Drug Alcohol Rev; 2002 Mar 15; 21(1):33-7. PubMed ID: 12189002
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
    Oliveira Mde L, Bastos FI, Telles PR, Hacker Mde A, Oliveira SA, Miguel JC, Yoshida CF.
    J Clin Virol; 2009 Mar 15; 44(3):200-6. PubMed ID: 19195927
    [Abstract] [Full Text] [Related]

  • 14. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L, Li J, Jalaludin B, Wand H, Jayasuriya R, Dixon D, Kaldor JM.
    Drug Alcohol Depend; 2007 Jul 10; 89(2-3):244-50. PubMed ID: 17289299
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
    Day C, Conroy E, Lowe J, Page J, Dolan K.
    Aust J Rural Health; 2006 Jun 10; 14(3):120-5. PubMed ID: 16706881
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.
    Backmund M, Reimer J, Meyer K, Gerlach JT, Zachoval R.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S330-5. PubMed ID: 15768343
    [Abstract] [Full Text] [Related]

  • 18. Experience of hepatitis C testing among injecting drug users in Sydney, Australia.
    Day CA, White B, Thein HH, Doab A, Dore GJ, Bates A, Holden J, Maher L.
    AIDS Care; 2008 Jan 15; 20(1):116-23. PubMed ID: 18278622
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of hepatitis C infection in injecting drug users in Zadar County, Croatia.
    Medić A, Dzelalija B, Sonicki Z, Zekanović D.
    Coll Antropol; 2008 Sep 15; 32(3):697-702. PubMed ID: 18982740
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.